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Abstract
Background: XMRV is a gammaretrovirus first identified in prostate tissues of Prostate Cancer (PC) patients and
later in the blood cells of patients with Chronic Fatigue Syndrome (CFS). Although XMRV is thought to use XPR1
for cell entry, it infects A549 cells that do not express XPR1, suggesting usage of other receptors or co-receptors.
Methods: To study the usage of different receptors and co- receptors that could play a role in XMRV infection of
lymphoid cells and GHOST (GFP- Human osteosarcoma) cells expressing CD4 along with different chemokine
receptors including CCR1, CCR2, etc., were infected with XMRV. Culture supernatants and cells were tested for
XMRV replication using real time quantitative PCR.
Results: Infection and replication of XMRV was seen in a variety of GHOST cells, LNCaP, DU145, A549 and Caski cell
lines. The levels of XMRV replication varied in different cell lines showing differential replication in different cell
lines. However, replication in A549 which lacks XPR1 expression was relatively higher than DU145 but lower than,
LNCaP. XMRV replication varied in GHOST cell lines expressing CD4 and each of the co- receptors CCR1-CCR8 and
bob. There was significant replication of XMRV in CCR3 and Bonzo although it is much lower when compared to
DU145, A549 and LNCaP.
Conclusion: XMRV replication was observed in GHOST cells that express CD4 and each of the chemokine
receptors ranging from CCR1- CCR8 and BOB suggesting that infectivity in hematopoietic cells could be mediated
by use of these receptors.
Introduction
A new gamma retrovirus, Xenotropic Murine leukaemia
Virus-related virus (XMRV), was identified in 2006 and
its association was claimed with prostate cancer (PC)
and chronic fatigue syndrome (CFS). A series of studies
from disparate geographical areas have failed to sub-
stantiate these claims. Recent studies have suggested
t h a tX M R Vm a yh a v ea r i s e ni nm i c et h r o u g hr e c o m b i -
nation of two proviruses [1].
Regardless of the controversies, XMRV is a culturable
virus capable of infecting different cell types like T and
B Lymphocytes, NK cells, etc., [2]. Intravenous inocula-
tion of Rhesus Macaques with XMRV showed organ-
specific cell tropism, infecting CD4 T cells in lymphoid
organs including the gastrointestinal lamina propria,
alveolar macrophages in lung, and epithelial/interstitial
cells in other organs, and cells of the reproductive tract
[3]. Many retroviruses are pathogenic (HIV-1) causing
severe disease but at the same time they have been used
in gene therapy which requires targeting of the virus to
the host cell through interactions between viral envelope
proteins and cell surface proteins. It is important to
determine the mode of its cell entry to define tropism,
and understand virus transmission and pathogenesis.
Biological process involves highly specific interactions
and infection of cells by viruses is no exception. Such
interactions are of major importance in pathogenic
viruses as they are potential drug targets. One such clas-
sic example is the entry of HIV-1 through a series of
interactions between the viral gp120 and cellular recep-
tor CD4 and co-receptor such as either CCR5 or
CXCR5 [4].
The xenotropic/polytropic subgroup of mouse leuke-
mia viruses (MLVs) all rely on the XPR1 receptor for
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among wild and laboratory mice, pathogenicity, strate-
gies used for transmission, and sensitivity to host
restriction factors [5]. XMRV is closely related to xeno-
tropic murine leukemia viruses MLVs (X-MLVs) [6].
The X-MLVs and polytropic MLVs (P-MLV) use Xpr1
as a receptor for cell entry [4,7,8], and so does XMRV
[9-11]. The recent identification of MLV and XMRV in
human prostate cancer tissues, peripheral blood mono-
nuclear cells (PBMCs) of chronic fatigue syndrome
patients, and the respiratory tract of immunocompro-
mised patients [12] raises the concern of a potential
threat to public health from cross-species transmission
of MLV related viruses.
Results and discussion
Infection and replication of XMRV was observed in a
variety of GHOST cells, LNCaP, DU145, A549 and
CaSki cell lines (Figure 1 and 2). The levels of XMRV
replication varied in different cell lines. However, repli-
cation in A549 which lacks XPR1 expression was rela-
tively high compared with DU145 but lower than levels
observed in LNCaP (Figure 1C and 2C). These findings
suggest that perhaps other molecules could serve as
receptors for this virus in addition to Xpr1. XMRV
replicated less efficiently in GHOST cell lines expressing
CD4 and each of the co- receptors CCR1 - CCR8 and
Bob compared with A549 and LNCaP. However, among
the GHOST cell lines there was significant replication of
XMRV in CCR3 and Bonzo expressing cells (Figure 1C
and 2C).
XMRV infection of GHOST cells that express CD4
and each of the chemokine receptors ranging from
CCR1- CCR8 and Bob suggests that infection and trop-
ism for hematopoietic cells could be mediated by use of
these receptors as XPR1 is not expressed in blood cells
a n dv e r yw e a k l ye x p r e s s e di nb o n em a r r o w( G e n e
Atlas). Replication of XMRV in A549 cells lacking XPR1
was much higher when compared with DU145 which
express XPR1. Furthermore, the cell line 293T expresses
XPR1 but did not support XMRV replication. These
findings clearly indicate the possibility of other receptors
for XMRV than XPR1. Interestingly CCR1, CCR2, and
CCR3 are expressed in A549 and Bonzo in PC-3,
DU145, LNCaP and A549 [13,14]. More research may
be needed to fully understand the scope and extent to
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Figure 1 Quantitation of XMRV RNA in 6 day infected culture supernatant. Figure 1(A)- GHOST cell lines expressing different Receptors.
Figure 1(B)- Lung epithelium A549 cell line; Prostate cancer cell lines DU 145 and LNCap. Figure 1(C) Comparison of Ghost Cell lines expressing
different receptors with A549, DU145 and LNCap which support high replication of XMRV.
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enter human cells and cross species susceptibility in line
with its xenotropic nature.
Materials and methods
Cells
GHOST (GFP- Human osteosarcoma) cells expressing
CD4 along with different chemokine receptors including
CCR1, CCR2, etc., were grown in Dulbecco’s modified
Eagle’s medium (DMEM Quality Biologics) with 10%
fetal bovine serum (FBS).
XMRV infectivity in various cell types
After three and six days of infection the XMRV levels in
supernatant and the integrated viral DNA in cells were
quantified using real time quantitative PCR. The values
were normalized by taking equal amounts of RNA/DNA
and compared with XMRV clone VP62-pcDNA3.1 stan-
dard (GenBank accession no. EF185282; obtained
through NIH AIDS Research and Reference Reagent
Program).
RNA isolation
Total RNA and DNA were isolated using Qiagen extrac-
tion kits.
Quantitative PCR
An equal amount of total RNA was used to quantify
XMRV levels using QuantiTect Probe RT-PCR kit (Qia-
gen). Real-time PCR Master Mix (Quantitect Probe RT-
PCR, Qiagen) was added with forward and reverse pri-
mers, probe, and cDNA or RNA in a total volume of 25
uL. Real-time PCR from RNA was done with the same
contents as above in addition to RT-mix (Qiagen) and
primer for Viral RNA. The mixture was incubated at 50°
C for 2 min (for RNA, 20 min), at 95°C for 10 min, and
then cycled at 95°C for 15 sec and 60°C for 60 sec 40
times, using the Applied Biosystems 7500 sequence
detection system.
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Figure 2 Quantitation of XMRV DNA in 6 day infected cultured Cells. Figure 2(A)- GHOST cell lines expressing different Receptors. Figure 2
(B)- Lung epithelium A549 cell line; Prostate cancer cell lines DU 145 and LNCap. Figure 2(C) Comparison of Ghost Cell lines expressing different
receptors with A549, DU145 and LNCap which support high replication of XMRV.
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